Metastsectomy a Feasible Treatment in Selected Patients with Gynecologic Malignancy.
- Author:
Eul Ju MOON
1
;
Yeonrk Jin PARK
;
Hee Hwahn CHUNG
;
Ju Won ROH
;
Jung Suk SIM
;
Sang Jae PARK
;
Jong Lim PARK
;
Jong Mog LEE
;
Jae Ill ZO
;
Dae Soon CHO
;
Sang Hoon SHIN
;
Heon YOO
;
Seung Hoon LEE
;
Sang Yoon PA
Author Information
1. N-C-C, Research Institute and Hospital, Goyang, Korea.
- Publication Type:Case Report
- Keywords:
Metastasectomy;
Liver metastasis;
Brain metastasis;
Lung metastasis;
Abdominal wall metastasis
- MeSH:
Abdominal Wall;
Bile;
Brain;
Female;
Follow-Up Studies;
Hepatectomy;
Humans;
Liver;
Lung;
Medical Records;
Metastasectomy;
Mortality;
Neoplasm Metastasis;
Ovary;
Recurrence;
Uterine Neoplasms;
Uterus
- From:Korean Journal of Obstetrics and Gynecology
2003;46(5):1029-1036
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
To report cases of metastasectomy for metastatic gynecologic malignancies, we reviewed the medical records of all patients who have undergone metastasectomy for metastatic gynecologic malignancies in Center for Uterine Cancer from June 2001 to October 2002. Six patients were identified with median age of 55 years (range 52-66 years). The metastatic sites and primary sites were as follows: 3 liver metastasis from ovary; 1 abdominal wall metastasis from uterus (endometrial cancer), 1 brain metastasis from ovary, 1 lung metastasis from uterus (sarcoma). The median disease free interval was 48 months (range 10 months-13 years). There was no perioperative mortality. Postoperative morbidity was tolerable with 1 case of bile leakage. In three patients with hepatectomy, one patient was dead of disease after 15 months, one patient is alive with disease at 20 months of follow up, one patient have no evidence of recurrence at 7 months follow up. The patient with brain metastasis was dead due to lung metastsis after 9 months later postoperatively. Remaining two patients with abdominal wall and lung metastasis have no evidence of tumor recurrence at 4, 7 months follow up respectively. Metastasectomy for metastatic gynecologic malignancies can be performed safely and may help prolong survival in carefully selected patients.
